114 related articles for article (PubMed ID: 16565605)
1. [Survival analysis for patients with hepatocellular carcinoma according to stage, liver function and treatment modalities].
Park KW; Park JW; Cho SH; Kim YI; Kim SH; Park HS; Lee WJ; Park SJ; Kim DY; Hong EK; Kim CM
Korean J Hepatol; 2006 Mar; 12(1):41-54. PubMed ID: 16565605
[TBL] [Abstract][Full Text] [Related]
2. [Five-year survival analysis of a cohort of hepatocellular carcinoma patients who treated at the National Cancer Center, Korea].
Park KW; Park JW; Kim TH; Choi JI; Kim SH; Park HS; Park SJ; Lee WJ; Shin HL; Kim CM
Korean J Hepatol; 2007 Dec; 13(4):530-42. PubMed ID: 18159151
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
Lee HS; Kim KM; Yoon JH; Lee TR; Suh KS; Lee KU; Chung JW; Park JH; Kim CY
J Clin Oncol; 2002 Nov; 20(22):4459-65. PubMed ID: 12431969
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Kwak HW; Park JW; Nam BH; Yu A; Woo SM; Kim TH; Kim SH; Koh YH; Kim HB; Park SJ; Lee WJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2014 Apr; 29(4):820-9. PubMed ID: 24325272
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization.
Liu MT; Li SH; Chu TC; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Lin JP
Jpn J Clin Oncol; 2004 Sep; 34(9):532-9. PubMed ID: 15466827
[TBL] [Abstract][Full Text] [Related]
8. Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience.
Lee SS; Shin HS; Kim HJ; Lee SJ; Lee HS; Hyun KH; Kim YH; Kwon BW; Han JH; Choi H; Kim BH; Lee JH; Kang HY; Shin HD; Song IH
Korean J Hepatol; 2012 Mar; 18(1):48-55. PubMed ID: 22511903
[TBL] [Abstract][Full Text] [Related]
9. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
10. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
[TBL] [Abstract][Full Text] [Related]
11. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
14. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
Allgaier HP; Deibert P; Olschewski M; Spamer C; Blum U; Gerok W; Blum HE
Int J Cancer; 1998 Dec; 79(6):601-5. PubMed ID: 9842968
[TBL] [Abstract][Full Text] [Related]
15. Prognosis and therapy for ruptured hepatocellular carcinoma: problems with staging and treatment strategy.
Hiraoka A; Kawamura T; Aibiki T; Okudaira T; Toshimori A; Yamago H; Nakahara H; Suga Y; Azemoto N; Miyata H; Miyamoto Y; Ninomiya T; Murakami T; Ishimaru Y; Kawasaki H; Hirooka M; Abe M; Matsuura B; Hiasa Y; Michitaka K
Eur J Radiol; 2015 Mar; 84(3):366-371. PubMed ID: 25554005
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.
Shin BS; Park MH; Jeon GS
Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371
[TBL] [Abstract][Full Text] [Related]
18. Treatment options in Western hepatocellular carcinoma: a prospective study of 224 patients.
Markovic S; Gadzijev E; Stabuc B; Croce LS; Masutti F; Surlan M; Berden P; Brencic E; Visnar-Perovic A; Sasso F; Ferlan-Marolt V; Mucelli FP; Cesar R; Sponza M; Tiribelli C
J Hepatol; 1998 Oct; 29(4):650-9. PubMed ID: 9824276
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for patients with stage IVB hepatocellular carcinoma and extension into the heart: prognostic and therapeutic implications.
Jun CH; Sim DW; Kim SH; Hong HJ; Chung MW; Cho SB; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
Yonsei Med J; 2014 Mar; 55(2):379-86. PubMed ID: 24532507
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features and treatment outcome of advanced hepatocellular carcinoma with inferior vena caval invasion or atrial tumor thrombus].
Kim SU; Kim YR; Kim DY; Kim JK; Lee HW; Kim BK; Han KH; Chon CY; Moon YM; Ahn SH
Korean J Hepatol; 2007 Sep; 13(3):387-95. PubMed ID: 17898555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
